Kliničke studije za Мигрена u državi Јута
8 studija za Мигрена traži učesnike na lokacijama u državi Јута.
Gradovi u državi Јута
Zvanični tekst studije (na engleskom)
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Advanced Research Institute Ogden, Ogden
Тражи се учесникФаза 4
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06972056A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Wasatch Clinical Research, LLC, Salt Lake City
- Highland Clinical Research, Salt Lake City
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07816367A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Pantheon Clinical Research, Bountiful
- J. Lewis Research, Inc. / Foothill Family Clinic Draper, Draper
- Advanced Research Institute, Ogden
- и још 3
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Pantheon Clinical Research /ID# 270259, Bountiful
- Alpine Research Organization - Clinton /ID# 276527, Clinton
- Highland Clinical Research /ID# 270281, Salt Lake City
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 9. 10. 2026. · NCT06810505Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Highland Clinical Research, Salt Lake City
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 9. 10. 2026. · NCT07646613Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pantheon Clinical Research /ID# 250703, Bountiful
- Highland Clinical Research /ID# 239362, Salt Lake City
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 9. 2026. · NCT05125302Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.